Thanks for posting this very interesting report from Bell Potter. It is extremely noteworthy. One point that caught my eye was that cardiologists who specialise in electrophysiology have given very strong feedback about the WiSE device. The benefits of better physiological placement that only EBR can provide was, from a market point of view, deliberately understated by Potters, who intimated their price target is very conservative indeed. Strong speculative buy is on the money!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $518.7M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.18 | $1.14 | $647.1K | 561.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2757 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 4664 | 2 |
View Market Depth
| Last trade - 15.59pm 14/07/2025 (20 minute delay) ? |
| EBR (ASX) Chart |